2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
No.4
“The Dipeptidyl Peptidase-4 Inhibitor Linagliptin is an Effective Therapeutic for Metabolic Liver Disease in Several Rodent Models of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH)” Boehringer Ingelheim GmbH & Co. KG
No.3
“Improvement of steatosis, inflammation, and fibrosis in a mouse model of steatohepatitis following treatment with galectin inhibitor” Galectin Therapeutics Inc.